Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/04 → 4/30/07 |
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel_Arm, 52-Week Dose Comparison Study of the Efficacy and Safety of 25mg QD and 50mg QD of OPC-6535 Oral Tablets and 800mg BID of Asacol
- De Villiers, Willem (PI)